Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Infectious Diseases
|
September 5, 1998
Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi
J C Rousselle, S M Callister, R F Schell, et al.
Science (New York, N.Y.)
|
February 11, 2017
A prominent glycyl radical enzyme in human gut microbiomes metabolizes <i>trans</i>-4-hydroxy-l-proline
B J Levin, Y Y Huang, S C Peck, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 20, 2000
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
A H Kissebah, G E Sonnenberg, J Myklebust, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Infectious Diseases
|
September 5, 1998
Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi
J C Rousselle, S M Callister, R F Schell, et al.
Science (New York, N.Y.)
|
February 11, 2017
A prominent glycyl radical enzyme in human gut microbiomes metabolizes <i>trans</i>-4-hydroxy-l-proline
B J Levin, Y Y Huang, S C Peck, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 20, 2000
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
A H Kissebah, G E Sonnenberg, J Myklebust, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
M Aldea, S Lenahan, M-A Locquet, et al.
Page
of 2